Canada markets closed

Emerald Health Therapeutics, Inc. (EMH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.19000.0000 (0.00%)
At close: 3:56PM EDT
Full screen
Previous Close0.1900
Open0.1900
Bid0.1900 x 0
Ask0.2000 x 0
Day's Range0.1850 - 0.1950
52 Week Range0.1200 - 1.4300
Volume125,298
Avg. Volume559,054
Market Cap38.706M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • Emerald Health Therapeutics Closes Shares for Debt Transaction
    Newsfile

    Emerald Health Therapeutics Closes Shares for Debt Transaction

    Vancouver, British Columbia--(Newsfile Corp. - September 16, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has closed its previously announced shares for debt financing. Further to its news release dated August 21, 2020, the Company has settled $625,000 of debt (the "Debt") payable to the holders (the "Holders") of convertible debentures of the Company issued on September 10, 2019 (the "Convertible Debentures"). The Debt represents accrued interest on the ...

  • Emerald Health Therapeutics and STENOCARE Receive Swedish Medicines Agency Approval to Provide Medical Cannabis Oil to Patients
    Newsfile

    Emerald Health Therapeutics and STENOCARE Receive Swedish Medicines Agency Approval to Provide Medical Cannabis Oil to Patients

    Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) -  Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") and STENOCARE A/S today announced that they have received special approval from the Swedish Medicines Agency to provide medical cannabis oil to Swedish patients who have applied via their doctor to use such products for treatment purposes.STENOCARE, located in Denmark, is a leading supplier of prescription-based medical cannabis products for patient treatment to help them improve ...

  • CNW Group

    IIROC Trading Resumption - EMH

    VANCOUVER, BC, Sept. 8, 2020 /CNW/ - Trading resumes in: Company: Emerald Health Therapeutics, Inc.